Importation

When states pass laws designed to control prescription drug costs, the pharmaceutical industry often responds with lawsuits claiming states are hindering interstate commerce and violating the federal Dormant Commerce Clause (DCC). NASHP’s legal experts believe states can craft drug cost policies that can withstand industry challenges. This brief by Anna Zaret and Darien Shankse provides insight and […]

Read More
  • State Health Policy Blog
    How States Can Avoid Dormant Commerce Clause Legal Challenges When Regulating Drug Costs

    How States Can Avoid Dormant Commerce Clause Legal Challenges When Regulating Drug Costs

    New state laws designed to control the costs of brand-name and generic prescription drugs often face legal challenges from the pharmaceutical industry. These lawsuits can vary depending on the individual state law, but recent industry lawsuits analyzed by the National Academy for State Health Policy (NASHP) share a common legal thread – drug manufacturers and […]

    Read More
  • State Health Policy Blog
    Utah’s Norman Thurston Takes a Red State Approach to Lower Rx Costs with a Bill to Import Drugs from Canada

    Utah’s Norman Thurston Takes a Red State Approach to Lower Rx Costs with a Bill to Import Drugs from Canada

    For more than a decade, Utah State Legislator and Director of the Office of Health Care Statistics Norman Thurston has worked to reform his state’s health care system, including its Medicaid program, and is considered one of the state’s “go-to” health care policymakers. Thurston, a Republican, has worked to reduce state spending on prescription drugs and […]

    Read More
  • Timberrrrrrrr! Chopping the Cost of Prescription Drugs

    Wednesday, October 25th 11:00AM-12:30PM States need innovative approaches to manage the rising cost of prescription medicines. The United States has the highest prescription drug prices in the world, which continue to rise at an alarming rate – averaging 10 percent annually since 2013. NASHP convenes state legislators and policy leaders who have taken bold steps […]

    Read More
  • State Health Policy Blog

    Supreme Court Decision Removes Barrier to Importing US Patented Drug Products at Lower Cost

    In its May 30, 2017 decision Impression Products, Inc. v Lexmark International Inc., the Supreme Court ruled that patent law cannot be used to prevent the resale of products back into the United States. The Court case specifically concerned printer toner cartridges, but it is an important ruling in the context of the domestic policy […]

    Read More
  • Publications

    State Wholesale Importation Program Explained

    Because the federal government has not been able to agree on an approach to constrain prescription drug prices, states need to address the problem. Study after study show how U.S. consumers pay the highest prices in the world for life-saving and life-enhancing drug treatments. The prices we pay may fund the research and development that […]

    Read More
  • State Health Policy Blog

    Managing High Drug Prices through Importation: We Can Get to “YES”

    There is growing public pressure to find an effective way to address the rising prices of prescription drugs. Multiple drug price bills await action in Congress and more than 80 bills have been introduced in state legislatures in 2017. Among the variety of approaches aimed at managing drug prices, importation from other countries is an […]

    Read More
  • State Health Policy Blog

    Update: What’s New in State Drug Pricing Legislation?

    With 80 bills introduced in 2017, there is a high level of interest in pharmaceutical pricing among state legislators. However, despite legislative sessions wrapping up, very few laws have been enacted. To date, bills have passed in Maryland, Montana, New Mexico, New York, and Utah. In 2016, Vermont led the way with a price transparency […]

    Read More
  • Publications
    States and the Rising Cost of Pharmaceuticals: A Call to Action

    States and the Rising Cost of Pharmaceuticals: A Call to Action

    As part of the 29th Annual State Health Policy Conference, held 17-19 in Pittsburgh, PA, NASHP released findings from our Pharmacy Costs Work Group aimed at addressing the increasingly rising costs of pharmaceuticals.  The solutions offered in the newly released findings serve as a toolbox for states. While they recognize the value of the pharmaceutical industry, state policymakers […]

    Read More
  • Publications

    States and Prescription Drugs: An Overview of State Programs to Rein in Costs

    States are significant purchasers of health care for Medicaid, inmates in correctional facilities, and public employees. Despite considerable efforts to maintain affordability, drug pricing continues to vex state budgets. While Medicaid is the largest single health expenditure in state budgets, spending on health care for public workers including state employees and retirees, legislators, judicial employees, […]

    Read More